Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03798743 |
|---|---|
| Brief Title: | Phase II Study on Sintilimab Combined With Docetaxel for Chemotherapy Failure Advanced NSCLC: the SUCCESS Study (SUCCESS) |
| First Submitted : | January 5, 2019 |
| First Submitted that Met QC Criteria : | January 8, 2019 |
| First Posted : | January 10, 2019 |
| Last Update Submitted that Met QC Criteria : | March 1, 2022 |
| Last Update Posted : | March 2, 2022 |